mBIOTA Labs

We’re proud to share that Krystyna Houser, founder of mBIOTA Labs, has been named to the 2025 Inc. Female Founders 500 list! This honor recognizes innovative and influential women who are shaping industries, and we couldn’t be more excited to see Krystyna’s work in microbiome science and biotech innovation acknowledged on this prestigious list. Thank you to Inc. Magazine for this incredible recognition, and congratulations to all the inspiring founders who are making an impact! #mBIOTAlabs #FemaleFounders500 #WomenInLeadership

Dr. Michael Weinstein interviews Dr. Ali Rezaie, about his new study showing that a new elemental diet from mBIOTA Labs can significantly improve patient compliance. The study assessed mBIOTA Elemental, a palatable elemental diet designed to address the barriers of poor taste and low adherence associated with traditional elemental diets. Participants using mBIOTA Elemental had complete compliance throughout the two-week therapy, a critical outcome when managing gastrointestinal disorders. Join Dr. Weinstein and Dr. Rezai as they explore how new innovations in elemental diets can help support patients with specific GI conditions and needs. #IndependentGI #Gastroenterology

Our founder, Krystyna Houser, turned her personal gut health challenges into a revolutionary solution that's transforming lives. In her recent Forbes feature, Krystyna shares how her journey led to the creation of mBIOTA Labs' proprietary elemental diet formula—an innovative approach that's reshaping digestive health care. Discover how mBIOTA Elemental? is setting a new standard in gut health and helping patients worldwide. #innovation #digestivehealth #elementaldiet

"The ‘food is medicine’ revolution is well underway." - Nicola Wodlinger, CEO mBIOTA Labs. Food allergies are on the rise, and stocking products that are free of common allergens can help you build a loyal customer base. Read more in this article from WholeFoods Magazine. #functionalfoods #foodasmedicine #mbiota #foodscience https://lnkd.in/ed5cMHBW

Who is ultimately responsible for making it as easy as possible for patients to “follow doctor’s orders?” mBIOTA Labs CEO Nicola Wodlinger weighs in for Healthcare Business Today #patientexperience #healthcare #mBIOTA

We are thrilled to share the groundbreaking findings from the first prospective clinical trial of the mBIOTA Elemental? diet for patients with small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO). In the study, a 100% patient compliance rate was achieved, making mBIOTA Elemental? the first orally ingested elemental diet to ever achieve this. Not only did this demonstrate our true palatability, but the trial also proved mBIOTA Elemental? to be highly effective at eradicating both SIBO and IMO, delivering on our mission to create a clinically proven therapy for GI dysfunction. To learn more about mBIOTA Labs and mBIOTA Elemental?, visit www.mbiotaelemental.com. #DDW2024 #GIHealth #ClinicalTrialResults

As Digestive Disease Week? (DDW) 2024 draws to a close, we celebrate remarkable advancements in gastrointestinal health. Among the highlights, mBIOTA Elemental? has emerged as the unanimous winner on taste, preferred by conference attendees 414:0 over the leading market competitor. For those who missed #DDW2024 or attended virtually, explore the study results and order samples directly to your health care practice at mbiotaelemental.com. Let’s continue revolutionizing GI health together! #DDW2024 #GIHealth #ClinicalTrialResults